Immune status improvement in piglets through the use of interferon-containing products during specific prevention of porcine pleuropneumonia

Specific prevention is one of the most effective methods for the control of infectious diseases causing considerable economic damage to commercial pig farms, among which is porcine pleuropneumonia. In order to improve the effectiveness of preventive vaccination, various immunomodulators that differ...

Full description

Bibliographic Details
Main Authors: A. G. Shakhov, L. Yu. Sashnina, V. A. Prokulevich, Yu. Yu. Vladimirova, M. I. Adodina
Format: Article
Language:English
Published: Da Vinci Media 2021-08-01
Series:Ветеринария сегодня
Subjects:
Online Access:https://veterinary.arriah.ru/jour/article/view/571
_version_ 1797224862756896768
author A. G. Shakhov
L. Yu. Sashnina
V. A. Prokulevich
Yu. Yu. Vladimirova
M. I. Adodina
author_facet A. G. Shakhov
L. Yu. Sashnina
V. A. Prokulevich
Yu. Yu. Vladimirova
M. I. Adodina
author_sort A. G. Shakhov
collection DOAJ
description Specific prevention is one of the most effective methods for the control of infectious diseases causing considerable economic damage to commercial pig farms, among which is porcine pleuropneumonia. In order to improve the effectiveness of preventive vaccination, various immunomodulators that differ in their origin and mechanism of action are used. The paper presents the results of the study of the effect of such products as biferon-S and prostimul containing species-specific recombinant interferons on the immune status of piglets during specific prevention of porcine pleuropneumonia. Tests were carried out in clinically healthy 30–35-day-old piglets immunized with Ingelvac® APPX vaccine (Boehringer Ingelheim Vetmedica GmbH, Germany). It was found that the use of biferon-S and prostimul together with the vaccine administration is accompanied by immune status improvement in the animals, which is manifested as an increase, in comparison with vaccinated animals that received no interferon-containing products (base case), in serum levels of γ-globulins – by 34.6 and 53.7% (in case of prostimul and β-globulins – by 10.1%), total immunoglobulins – by 32.8 and 37.8%, large circulating immune complexes – by 37.5 and 52.6%, a less significant increase in the levels of small complexes and, as a result, pathogenicity coefficient reduction by 5.4 and 12.4%, respectively. Tests for post-vaccination immunity levels in piglets showed a 3.8-fold increase in the levels of specific antibodies against the antigen of porcine pleuropneumonia agent, and in case of the vaccine administration in combination with biferon-S and prostimul – a 4.0-fold and 4.9-fold increase, respectively. The use of prostimul was accompanied by a more considerable improvement of immune status in the piglets, and this is attributable to the fact that vitamins А, Е and С, which have antioxidant properties and improve the effectiveness of interferons, natural resistance and specific immunity, are included in its composition in addition to recombinant type 1 cytokine.
first_indexed 2024-03-09T02:49:03Z
format Article
id doaj.art-379989bd97cf427ea30bd67ac8b0b18d
institution Directory Open Access Journal
issn 2304-196X
2658-6959
language English
last_indexed 2024-04-24T13:59:52Z
publishDate 2021-08-01
publisher Da Vinci Media
record_format Article
series Ветеринария сегодня
spelling doaj.art-379989bd97cf427ea30bd67ac8b0b18d2024-04-03T12:48:50ZengDa Vinci MediaВетеринария сегодня2304-196X2658-69592021-08-0110319720210.29326/2304-196X-2021-3-38-197-202518Immune status improvement in piglets through the use of interferon-containing products during specific prevention of porcine pleuropneumoniaA. G. Shakhov0L. Yu. Sashnina1V. A. Prokulevich2Yu. Yu. Vladimirova3M. I. Adodina4Federal State Budgetary Scientific Institution “All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy” (FSBSI “ARVRIPP&T”)Federal State Budgetary Scientific Institution “All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy” (FSBSI “ARVRIPP&T”)Belarusian State University (BSU)Federal State Budgetary Scientific Institution “All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy” (FSBSI “ARVRIPP&T”)Federal State Budgetary Scientific Institution “All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy” (FSBSI “ARVRIPP&T”)Specific prevention is one of the most effective methods for the control of infectious diseases causing considerable economic damage to commercial pig farms, among which is porcine pleuropneumonia. In order to improve the effectiveness of preventive vaccination, various immunomodulators that differ in their origin and mechanism of action are used. The paper presents the results of the study of the effect of such products as biferon-S and prostimul containing species-specific recombinant interferons on the immune status of piglets during specific prevention of porcine pleuropneumonia. Tests were carried out in clinically healthy 30–35-day-old piglets immunized with Ingelvac® APPX vaccine (Boehringer Ingelheim Vetmedica GmbH, Germany). It was found that the use of biferon-S and prostimul together with the vaccine administration is accompanied by immune status improvement in the animals, which is manifested as an increase, in comparison with vaccinated animals that received no interferon-containing products (base case), in serum levels of γ-globulins – by 34.6 and 53.7% (in case of prostimul and β-globulins – by 10.1%), total immunoglobulins – by 32.8 and 37.8%, large circulating immune complexes – by 37.5 and 52.6%, a less significant increase in the levels of small complexes and, as a result, pathogenicity coefficient reduction by 5.4 and 12.4%, respectively. Tests for post-vaccination immunity levels in piglets showed a 3.8-fold increase in the levels of specific antibodies against the antigen of porcine pleuropneumonia agent, and in case of the vaccine administration in combination with biferon-S and prostimul – a 4.0-fold and 4.9-fold increase, respectively. The use of prostimul was accompanied by a more considerable improvement of immune status in the piglets, and this is attributable to the fact that vitamins А, Е and С, which have antioxidant properties and improve the effectiveness of interferons, natural resistance and specific immunity, are included in its composition in addition to recombinant type 1 cytokine.https://veterinary.arriah.ru/jour/article/view/571porcine pleuropneumoniapigletsspecific preventionvaccineimmune statusbiferon-sprostimulvitamins ае and с
spellingShingle A. G. Shakhov
L. Yu. Sashnina
V. A. Prokulevich
Yu. Yu. Vladimirova
M. I. Adodina
Immune status improvement in piglets through the use of interferon-containing products during specific prevention of porcine pleuropneumonia
Ветеринария сегодня
porcine pleuropneumonia
piglets
specific prevention
vaccine
immune status
biferon-s
prostimul
vitamins а
е and с
title Immune status improvement in piglets through the use of interferon-containing products during specific prevention of porcine pleuropneumonia
title_full Immune status improvement in piglets through the use of interferon-containing products during specific prevention of porcine pleuropneumonia
title_fullStr Immune status improvement in piglets through the use of interferon-containing products during specific prevention of porcine pleuropneumonia
title_full_unstemmed Immune status improvement in piglets through the use of interferon-containing products during specific prevention of porcine pleuropneumonia
title_short Immune status improvement in piglets through the use of interferon-containing products during specific prevention of porcine pleuropneumonia
title_sort immune status improvement in piglets through the use of interferon containing products during specific prevention of porcine pleuropneumonia
topic porcine pleuropneumonia
piglets
specific prevention
vaccine
immune status
biferon-s
prostimul
vitamins а
е and с
url https://veterinary.arriah.ru/jour/article/view/571
work_keys_str_mv AT agshakhov immunestatusimprovementinpigletsthroughtheuseofinterferoncontainingproductsduringspecificpreventionofporcinepleuropneumonia
AT lyusashnina immunestatusimprovementinpigletsthroughtheuseofinterferoncontainingproductsduringspecificpreventionofporcinepleuropneumonia
AT vaprokulevich immunestatusimprovementinpigletsthroughtheuseofinterferoncontainingproductsduringspecificpreventionofporcinepleuropneumonia
AT yuyuvladimirova immunestatusimprovementinpigletsthroughtheuseofinterferoncontainingproductsduringspecificpreventionofporcinepleuropneumonia
AT miadodina immunestatusimprovementinpigletsthroughtheuseofinterferoncontainingproductsduringspecificpreventionofporcinepleuropneumonia